British drug major sold brand drug to German pharma company Gruenenthal
Cyber-Attack: Dr Reddy's Labs said on Thursday it had isolated all its data center services as a preventive measure following a cyber-attack.
Dr Reddy's Share Price: The stock rose by Rs 131.15 to Rs 5,213.50 apiece on the BSE during the session, having begun the day stronger at Rs 5,202.00 compared to its previous close of Rs 5,082.35.
The Nifty Pharma index - which captures the performance of 10 drug makers in the country, including Dr Reddy's, Lupin, Cipla and Sun Pharma - jumped as much as 3.66 per cent.
Cipla Share Price: By 11:22 am, 6.88 lakh Cipla shares had changed hands on the BSE, as against an average of 3.49 lakh over the past two weeks.
The institute said on Friday it will get funding to support manufacturing for candidate vaccines from AstraZeneca and Novavax.
Zydus plans to complete late-stage trials for ZyCoV-D by February or March and could produce up to 100 million doses a year initially.
Aquinox Pharmaceuticals is a research and development company focused on pharmaceutical products for the purpose of their commercialisation, Sun Pharma said.
Glenmark denied making any claims that "favipiravir alone" is effective in treatment of mild-to-moderate COVID-19 patients.
The drug, which is also used to cure the skin disease psoriasis, was cleared by the Drug Controller General of India (DCGI) for usage in the country.
Sources said the first batch of 10,000 vials had been printed with a price of Rs 4,000, Rs 800 below the cheapest option, launched by European competitor Mylan this week.
Piramal Pharma Share Price: Piramal Enterprises shares rose to as high as Rs 1,387.55 apiece on the BSE during the session.